SCHEMBL7979624

SCHEMBL7979624

Cc1cc(Br)c(Nc2nc3cccc([N+](=O)[O-])c3n3cncc23)c(Br)c1

nearest known ligand 0.76

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7981230 0.92 LCK (0.73) LCK
SCHEMBL7969975 0.91 LCK (0.77) LCK
SCHEMBL7970454 0.90 LCK (0.86) LCK
SCHEMBL7969717 0.90 LCK (0.69) LCK
SCHEMBL7983990 0.88 LCK (0.83) LCK
SCHEMBL7981032 0.88 LCK (0.67) LCK
SCHEMBL7981228 0.87 LCK (1.00) LCK
SCHEMBL7984181 0.86 LCK (0.75) LCK
SCHEMBL7979850 0.86 LCK (0.75) LCK
SCHEMBL7983709 0.84 LCK (0.70) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed